《大行報告》瑞銀料港交所(00388.HK)中期收入可受惠HIBOR趨升 重申「買入」評級
瑞銀發表報告,相信與內地互聯互通仍是港交所(00388.HK)的主要投資主題,而近期的主要發展包括「ETF通」和「互換通」。該行認為,港交所的資產類別向固定收入及貨幣相關產品發展,可有助分散其收入來源,繼而進一步加強集團的韌性,及支持其較全球同業有估值溢價。
瑞銀下調港交所今年盈利預測2%,主要反映市場走勢,並預料HIBOR趨升能夠支撐集團的中期收入,因其主要投資收益由是利率推動,而且在下半年會更明顯。
基於明年預測市盈率41倍,瑞銀維持港交所股份「買入」評級及目標價480元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.